RT Journal Article
SR Electronic
T1 A novel sample pooling strategy and its application for mass screening of SARS-CoV-2 in an outbreak of COVID-19 in Vietnam
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.11.20192484
DO 10.1101/2020.09.11.20192484
A1 Thanh, Ton That
A1 Nhan, Nguyen Thi Thanh
A1 Mai, Huynh Kim
A1 Trieu, Nguyen Bao
A1 Huy, Le Xuan
A1 Thuy, Ho Thi Thanh
A1 Chung, Le Thanh
A1 Anh, Nguyen Ngoc
A1 Hong, Nguyen Thi Thu
A1 Thang, Bui Duc
A1 Thu, Nguyen Thi Hoai
A1 Chi, Le Thi Kim
A1 Hanh, Nguyen Thi
A1 Hoang, Nguyen Huy
A1 Van Vinh Chau, Nguyen
A1 Thwaites, Guy
A1 Hung, Do Thai
A1 Van Tan, Le
A1 Yen, Ngo Thi Kim
YR 2020
UL http://medrxiv.org/content/early/2020/09/11/2020.09.11.20192484.abstract
AB We present a sample pooling approach and the results of its application for mass screening of SARS-CoV-2 in >96,000 asymptomatic individuals. Our approach did not compromise the sensitivity of PCR, while increasing the throughput and reducing 77% of the costs. 22/32 asymptomatic cases would have been missed without mass screening.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; Ms Ho Thi Thanh Thuy is a vice director of Viet A Company; no other relationships or activities that could appear to have influenced the submitted work.Funding StatementThe study was funded by Da Nang Peoples Committee, Da Nang, Vietnam. We would like to thank the World Health Organization and the US Centers for Disease Control and Prevention for their support with the COVID-19 diagnostic reagents. LVT and GT are supported by the Wellcome Trust of Great Britain (204904/Z/16/Z and 106680/B/14/Z, respectively)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present work formed part of the response to COVID-19 outbreaks that was approved by Da Nang Department of Health. Accordingly, obtaining inform consent from individuals was deemed unnecessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are presented in the ms.